AmCad BioMed Corporation

TPEX:4188 Stock Report

Market Cap: NT$1.3b

AmCad BioMed Past Earnings Performance

Past criteria checks 0/6

AmCad BioMed's earnings have been declining at an average annual rate of -7.3%, while the Medical Equipment industry saw earnings growing at 9.6% annually. Revenues have been declining at an average rate of 4.7% per year.

Key information

-7.3%

Earnings growth rate

-6.9%

EPS growth rate

Medical Equipment Industry Growth11.5%
Revenue growth rate-4.7%
Return on equity-8.4%
Net Margin-93.7%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Companies Like AmCad BioMed (GTSM:4188) Are In A Position To Invest In Growth

Apr 19
Companies Like AmCad BioMed (GTSM:4188) Are In A Position To Invest In Growth

AmCad BioMed (GTSM:4188) Is In A Good Position To Deliver On Growth Plans

Jan 04
AmCad BioMed (GTSM:4188) Is In A Good Position To Deliver On Growth Plans

Revenue & Expenses Breakdown

How AmCad BioMed makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

TPEX:4188 Revenue, expenses and earnings (TWD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2458-555447
30 Jun 2464-485147
31 Mar 2463-505146
31 Dec 2365-455144
30 Sep 2356-555149
30 Jun 2353-584853
31 Mar 2355-564853
31 Dec 2262-534854
30 Sep 2275-404852
30 Jun 2289-254949
31 Mar 2291-224850
31 Dec 2186-264651
30 Sep 2179-244447
30 Jun 2166-344549
31 Mar 2164-314648
31 Dec 2064-354949
30 Sep 2058-495553
30 Jun 2060-515754
31 Mar 2071-485956
31 Dec 1984-386058
30 Sep 1987-365959
30 Jun 1985-436062
31 Mar 1975-516065
31 Dec 1872-456267
30 Sep 1861-455764
30 Jun 1856-395457
31 Mar 1840-444752
31 Dec 1721-594144
30 Sep 1719-543641
30 Jun 1713-533340
31 Mar 1713-543538
31 Dec 1610-553238
30 Sep 167-583237
30 Jun 164-603037
31 Mar 160-582436
31 Dec 150-622836
30 Sep 150-592833
30 Jun 150-582932
31 Mar 150-552730
31 Dec 140-431926
30 Sep 140-401527
30 Jun 140-32925
31 Mar 140-25621

Quality Earnings: 4188 is currently unprofitable.

Growing Profit Margin: 4188 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 4188 is unprofitable, and losses have increased over the past 5 years at a rate of 7.3% per year.

Accelerating Growth: Unable to compare 4188's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 4188 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (1.7%).


Return on Equity

High ROE: 4188 has a negative Return on Equity (-8.42%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies